Case report of pneumatosis intestinalis secondary to sunitinib treatment for refractory gastrointestinal stromal tumor

Anticancer Research

Volumn 31, Issue 10, 2011, Pages 3429-3432

  Jarkowski III, Anthony ^a   Hare, Ryan ^a   Francescutti, Valerie ^a   Wilkinson, Neal ^a   Khushalani, Nikhil ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Gastrointestinal stromal tumor; Pneumatosis intestinalis; Sunitinib

Indexed keywords

CD34 ANTIGEN; CYTOKERATIN 7; IMATINIB; NILOTINIB; STEM CELL FACTOR RECEPTOR; SUNITINIB; VENLAFAXINE;

ABDOMINAL TUMOR; AGED; ARTICLE; BIOPSY; BLOATING; CASE REPORT; CAUCASIAN; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; DRUG DOSE ESCALATION; DRUG WITHDRAWAL; DYSGEUSIA; DYSPEPSIA; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HYPERTENSION; MALE; NAUSEA; PAIN; PNEUMATOSIS INTESTINALIS; PRIORITY JOURNAL; SYMPTOM;

AGED; DRUG RESISTANCE, NEOPLASM; GASTROINTESTINAL STROMAL TUMORS; HUMANS; INDOLES; MALE; PNEUMATOSIS CYSTOIDES INTESTINALIS; PYRROLES; RADIOGRAPHY, ABDOMINAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80054753227     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Koreishi A, Lauwers G and Misdraji J: Pneumatosis intestinalis: A challenging biopsy diagnosis. Am J Surg Pathol 31: 1469-1475, 2007. (Pubitemid 47482459)
2. Shih T and Lindley C: Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies. Clinical Ther 28: 1779-1802, 2006. (Pubitemid 46038527)
3. Coriat R, Ropert S, Mir O, Billemont B, Chaussade S, Massault P,Blanchet B, Vignaux O and Goldwasser F: Pneumatosis intestinalis associated with treatment of cancer patients with the vascular growth factor receptor tyrosine kinase inhibitors sorafenib and sunitinib. Investi New Drugs pp. 1-4, 2010.
4. Flaig T, Kim F, La Rosa F, Breaker K, Schoen J and Russ P: Colonic pneumatosis and intestinal perforations with sunitinib treatment for renal cell carcinoma. Invest New Drugs 27: 83-87, 2009.
5. St. Peter SD, Abbas MA and Kelly KA: The spectrum of pneumatosis intestinalis. Arch Surgery 138: 68-75, 2003. (Pubitemid 36055653)
6. Ho L, Paulson E and Thompson W: Pneumatosis intestinalis in the adult: benign to life-threatening causes. Am J of Roentgenol 188: 1604-1613, 2007. (Pubitemid 46866865)
7. Rock E, Goodman V, Jiang J, Mahjoob K, Verbots S, Morse D, Dagher R and Justice R: Food and Drag Administration drag approval summary: Sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma. Oncologist 12: 107-113, 2007. (Pubitemid 46143508)
8. Faivre S, Delbaldo C, Vera K, Robert C, Lozahic S, Lassau N, Bello C, Deprimo S, Brega N, Massimini G, Armand JP, Scigalla P and Raymond E: Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer. J Clin Oncology 24: 25-35, 2006. (Pubitemid 46630490)
9. Mendel DB, Douglas Laird A, Xin X, Louie SG, Christensen JG, Li G, Schrek RE, Abrams TJ, Ngai TJ, Lee LB, Murray LJ, Carver J, Chan E, Moss KG, Haznedar JO, Sukbunthemg J, Blake RA, Sun L, Tang C, Miller T, Shirazian S, McMahon G and Cherrington JM: In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: Determination of a pharmacokinetic/pharmacodynamic relationship. Clin Cancer Res 9: 327-337, 2003. (Pubitemid 36109749)
10. Chouhan JD, Zamarripa DE, Lai PH, Oramasionwu CU and Grabinski JL: Sunitinib (Sutent(registered trademark)): A novel agent for the treatment of metastatic renal cell carcinoma. J Oncology Pharm Pract 13: 5-16, 2007. (Pubitemid 46894733)
11. Naranjo CA, Busto U and Sellers EM: A method for estimating the probability of adverse drug reactions. Clin Pharmacol and Ther 30: 239-245, 1981. (Pubitemid 12149145)
12. Goodman VL, Rock EP, Dagher R, Ramchandani RP, Abraham S, Gobburu JVS, Booth BP, Verbois SL, Morse DE, Liang CY, Chidambaram N, Jiang JX, Tang S, Mahjoob K, Justice R and Pazdur R: Approval summary: Sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma. Clin Cancer Res 13: 1367-1373, 2007. (Pubitemid 46450424)
13. Saif MW, Elfiky A and Salem RR: Gastrointestinal perforation due to bevacizumab in colorectal cancer. Ann Surgi Oncol 14: 1860-1869, 2007. (Pubitemid 46870935)
14. Jain RK: Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy. Nat Med 7: 987-989, 2001.
15. Wayne E, Ough M, Wu A, Liao J, Andresen KJ, Kuehn D and Wilkinson N: Management algorithm for pneumatosis intestinalis and portal venous gas: treatment and outcome of 88 consecutive cases. J Gastrointest Surg 14: 437-448, 2010.